Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: A phase IA - B study

Annals of Oncology

Volumn 7, Issue 3, 1996, Pages 317-319

  Goey, S H ^a   Eggermont, A M M ^a   Oskam, R ^b   Wiggers, Th ^a   Bolhuis, R L H ^a   Stoter, G ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b Chiron BV   (Netherlands)

Author keywords

Colorectal cancer; Hepatic artery infusion; Interleukine 2

Indexed keywords

HEPARIN; INTERLEUKIN 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; HEPATIC ARTERY; HUMAN; INFLUENZA; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER TOXICITY; MALE; NAUSEA; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOSIS; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTERLEUKIN-2; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029874762     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010579     Document Type: Article

References (7)

1. Chang AE, Schneider PD, Sugarbaker PH. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-93.
2. Rosenberg SA, Lotze MT, Yang JC et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 1989; 210: 474-85.
3. Schleef RR, Bevilacqua MP, Sawdey M et al. Cytokine activation of vascular endothelium. J Biol Chem 1988; 26: 5797-803.
4. Baars UW, De Boer JP, Wagstaff J et al. Interleukin-2 induces activation of coagulation and fibrinolysis: Resemblance to the changes seen during experimental endotoxaemia. Br J Haematol 1992; 82: 295-301.
5. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
6. Mavligit GM, Zukiwski AA, Gutterman JU et al. Splenic versus hepatic artery infusion of interteukin-2 in patients with liver metastases. J Clin Oncol 1990; 8: 319-24.
7. Klasa RJ, Silver HKB, Kong S. In vivo induction of lymphokine activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy. Cancer Res 1990; 50: 4906-10.